BRISTOL-MYERS SQUIBB CO (BMY:NYSE)
$61.55 -0.06 (-0.0974%)
Analysed BRISTOL-MYERS SQUIBB CO (BMY:NYSE) News Sources
Another autoimmune CAR-T death; Treasury zeroes in on China deals
26-10-2026
biopharmadive.com
RiskVantage AI Unveils Explainable, Sovereign AI for the $75 Billion Contract and Deal Legal Market at Dubai AI Festival
26-10-2026
yahoo.com
Bristol Myers Squibb: Bargain Buy or Value Trap?
26-10-2026
fool.com
Bristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own Stock
26-10-2026
marketbeat.com
3 Cheap Dividend Stocks I'd Buy Without Any Hesitation
26-10-2026
fool.com
What Does Bristol Myers Squibb (BMY) Zola Cel MS Trial Update Mean?
27-10-2026
yahoo.com
Bristol Myers Squibb’s Cancer Drug Just Doubled Survival Time Without Progression — Here’s Why It Matters
27-10-2026
fool.com
Bristol Myers Squibb (BMY) Stock Still Looks Reasonable Below Fair Value
27-10-2026
yahoo.com
Bristol Myers Squibb (BMY) Stock Fair Value Edges Lower On Split Analyst Views
27-10-2026
yahoo.com
Bristol-Myers Squibb (BMY) Q3 earnings: what to expect
28-10-2026
yahoo.com
What is the current price of BRISTOL-MYERS SQUIBB CO (BMY:NYSE)?
The current price of BRISTOL-MYERS SQUIBB CO (BMY:NYSE) is $61.55.
BRISTOL-MYERS SQUIBB CO (BMY:NYSE) absolute price change since previous trading day?
The absolute price change of BRISTOL-MYERS SQUIBB CO (BMY:NYSE) since the previous trading day is $-0.06.
BRISTOL-MYERS SQUIBB CO (BMY:NYSE) percentage price change since previous trading day?
The percentage price change of BRISTOL-MYERS SQUIBB CO (BMY:NYSE) since the previous trading day is -0.0974%.
What is the most recent average sentiment score for BRISTOL-MYERS SQUIBB CO (BMY:NYSE)?
The most recent average sentiment score for BRISTOL-MYERS SQUIBB CO (BMY:NYSE) is 49 out of 100.
What is the most recent average sentiment for BRISTOL-MYERS SQUIBB CO (BMY:NYSE)?
The most recent sentiment for BRISTOL-MYERS SQUIBB CO (BMY:NYSE) is .
SEC-8K** Filing Available For BRISTOL-MYERS SQUIBB CO (BMY:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.